Author/Authors :
Moscoso , Ana Department of Child and Adolescent Psychiatry - Reference Center for Rare Psychiatric Diseases - APHP - Groupe Hospitalier Pitié-Salpêtrière - Université Sorbonne - Paris, France , Julien, Aurélie Department of Child and Adolescent Psychiatry - Reference Center for Rare Psychiatric Diseases - APHP - Groupe Hospitalier Pitié-Salpêtrière - Université Sorbonne - Paris, France , Tanet, Antoine Department of Child and Adolescent Psychiatry - Reference Center for Rare Psychiatric Diseases - APHP - Groupe Hospitalier Pitié-Salpêtrière - Université Sorbonne - Paris, France , Consoli, Angèle Department of Child and Adolescent Psychiatry - Reference Center for Rare Psychiatric Diseases - APHP - Groupe Hospitalier Pitié-Salpêtrière - Université Sorbonne - Paris, France , Pagnard, Martine Department of Child and Adolescent Psychiatry - Reference Center for Rare Psychiatric Diseases - APHP - Groupe Hospitalier Pitié-Salpêtrière - Université Sorbonne - Paris, France , Trevisan, France Department of Child and Adolescent Psychiatry - Reference Center for Rare Psychiatric Diseases - APHP - Groupe Hospitalier Pitié-Salpêtrière - Université Sorbonne - Paris, France , Cohen, David Department of Child and Adolescent Psychiatry - Reference Center for Rare Psychiatric Diseases - APHP - Groupe Hospitalier Pitié-Salpêtrière - Université Sorbonne - Paris, France , Kemlin, Isabelle Centre de Référence des Neuro bromatoses et Service de Neurologie Pédiatrique - AP-HP - Hôpital Armand Trousseau - GHUEP - Paris, France , Rodriguez, Diana Sorbonne Université - Hôpital Armand Trousseau - F-75012 - Paris, France
Abstract :
Cognitive and behavioural problems associated with Neurobromatosis type 1 (NF1) are common sources of distress and the reasons behind seeking help. Here we describe patients with NF1 or NF1-like phenotypes referred to a Tier 3 Child and Adolescent Psychiatry Department and highlight the benets of a multidisciplinary assessment. Methods. Prospective data were gathered from NF1 patients aged 7–15 years, referred by the NF1 Referral Centre due to additional diculties either in management or diagnosis. For the selected cases, we performed a psychiatric assessment, a tailored neuropsychological evaluation based on clinical demands and history, broad speech and motor skills evaluations if there were concerns regarding language, motor abilities and/or learning diculties and autism specic evaluations, if clinically relevant. No exclusion criteria were applied. Results. Complex NF1 cases represented only 5% of the patients (11/224). Assessments revealed the complexity of NF1 phenotype and a variety of problems including learning diculties, emotional problems and autism spectrum disorders. Specic evaluations of language, motor, attentional and neurovisual domains were essential to guide tailored intervention strategies. Conclusions. In terms of clinical implications, the heterogeneity of NF1 phenotypical manifestations needs to be considered when developing assessment and remediation approaches for children with complex NF1
Keywords :
Clinical Management , Children and Adolescents , Neurofibromatosis Type 1 , Phenotypes and Complex Behavioural Manifestations , Multidisciplinary , Dimensional Approach , NF1